Advanced Search
Share
Latest issue
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy
ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

RSS
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2024
1.6
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
2.0
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.360
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
0.754
View more metrics
Open Access Option
Hide
Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation
Moazzam Shahzad, Muhammad Kashif Amin, Maggie Nelson, Abhinav Vyas, Joe S. Al-Ramahi, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, ... Muhammad Umair Mushtaq
Full text access
Uncorrected Proof. Available online 11 August 2025
Share
Linkedin
whatsapp
Email
Electroacupuncture as a tool to stimulate bone marrow megakaryocytes in mice: A pilot study
Luiza P.R. dos Santos Mariani, Rita M.V.M. Rocha, Lidiane M.B. Leite, Alexandra C. Senegaglia, Pedro V. Michelotto
Full text access
Uncorrected Proof. Available online 11 August 2025
Share
Linkedin
whatsapp
Email
Overall survival in multiple myeloma in Brazil: A cohort of 16 years
Deborah Marta do Santos Oliveira, Adriano de Paula Sabino, Francisco de Assis Acurcio, Isabella Zuppo, Juliana Alvares Teodoro, Pâmela Santos Azevedo, Isabela Cristina Menezes de Freitas, Wallace Mateus Prata, ... Augusto Afonso Guerra Junior
Full text access
Uncorrected Proof. Available online 11 August 2025
Share
Linkedin
whatsapp
Email
View all Ahead of print
Latest issue
Issue
portada-S2531137925X00055Vol. 47. Issue 3.
(julho - setembro 2025)
Original Articles
Clinical characteristics and outcomes of non-tuberculous mycobacterial pulmonary infections after hematopoietic stem cell transplantation: A retrospective cohort study
Zahia Esber, Hamza Salam, Shefali Godara, Ayman Soubani
Hematol Transfus Cell Ther. 2025;47:103841
Full text access
Share
Linkedin
whatsapp
Email
Hematological ratios and cytokine profiles in heterozygous beta-thalassemia
Ana Carolina Marques Ciceri, Laura Eduarda de Oliveira, Ana Luísa Richter, José Antonio Mainardi de Carvalho, Maylla Rodrigues Lucena, Guilherme Wataru Gomes, Maria Stella Figueiredo, Magnun Nueldo Nunes dos Santos, ... Clóvis Paniz
Hematol Transfus Cell Ther. 2025;47:103845
Full text access
Share
Linkedin
whatsapp
Email
Long-term follow-up results of ruxolitinib as salvage therapy for chronic graft-versus-host disease
Neslihan Mandaci Sanli, Esen Karakuş
Hematol Transfus Cell Ther. 2025;47:103835
Full text access
Share
Linkedin
whatsapp
Email
The impact of pathogen reduction on ABO isoagglutinin titers in apheresis platelets
Mikayel Yeghiazaryan, Yembur Ahmad, Jessie Singer, Vaanush Nazaryan, Craig Fletcher, Yamac Akgun
Hematol Transfus Cell Ther. 2025;47:103840
Full text access
Share
Linkedin
whatsapp
Email
View latest issue View all issues
Editorial Board
Eduardo Magalhães Rego
Eduardo Magalhães Rego, MD, PhD
Universidade de São Paulo, São Paulo, Brazil
View editorial board
All issues
portada-July - September
July - September
Volume 47 . Issue. 3
portada-April - June
April - June
Volume 47 . Issue. 2
portada-January - March
January - March
Volume 47 . Issue. 1
portada-October - December
October - December
Volume 46 . Issue. 4
Pages 325-578
View all issues
Supplements
portada-July
July
Volume 47. Issue. S2
XVI Eurasian Hematology Oncology Congress
portada-May
May
Volume 47. Issue. S1
2º Congresso CancerThera
portada-December
December
Volume 46. Issue. S7
Hematology Specialist Association 18. National Congress
Pages S1-S78
portada-December
December
Volume 46. Issue. S6
Pages S1-S444
View all supplements
Instructions for authors
Publish in Hematology, Transfusion and Cell Therapy
Most often read
Letter to the Editor
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?
Daniel Mazza Matos
10.1016/j.htct.2024.05.007
Hematol Transfus Cell Ther. 2025;47:
This article has been read 2.634 times
View all Most Often read articles

Subscribe to our newsletter

Publish in
Hematology, Transfusion and Cell Therapy
cope-logo
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Hematology, Transfusion and Cell Therapy